CompanyDrug

Novo Nordisk’s Sogroya Wins NMPA Approval for Pediatric Growth Hormone Deficiency

CompanyDrug

J&J’s Amivantamab Subcutaneous Wins China Approval for NSCLC

CompanyDeals

Hybio Pharmaceutical, Dr. Reddy’s Forge Peptide API Partnership

CompanyPolicy / Regulatory

NDRC Expands Foreign Investment in Healthcare with 2025 Catalogue

NMPA Issues Internet Pharma Info Rules Requiring Record-Filing Display
Policy / Regulatory

NMPA Issues Internet Pharma Info Rules Requiring Record-Filing Display

Shionogi Acquires RADICAVA ALS Business for $2.5 Billion from Tanabe Pharma
CompanyDeals

Shionogi Acquires RADICAVA ALS Business for $2.5 Billion from Tanabe Pharma

Novo Nordisk’s Wegovy Wins China Cardiovascular Approval in Weight-Loss Market Expansion
CompanyDrug

Novo Nordisk’s Wegovy Wins China Cardiovascular Approval in Weight-Loss Market Expansion

Aosaikang’s Delafloxacin Wins NMPA Approval as First Fluoroquinolone for China Infections
CompanyDrug

Aosaikang’s Delafloxacin Wins NMPA Approval as First Fluoroquinolone for China Infections

Coherent Biopharma Licenses PDC CBP-1018 to MultiValent in $2 Billion Prostate Cancer Deal
CompanyDeals

Coherent Biopharma Licenses PDC CBP-1018 to MultiValent in $2 Billion Prostate Cancer Deal

3SBio’s rhTPO Wins NMPA Approval for Liver Disease Thrombocytopenia Before Surgery
CompanyDrug

3SBio’s rhTPO Wins NMPA Approval for Liver Disease Thrombocytopenia Before Surgery

Gilead’s Seladelpar Wins China Hainan Approval for PBC Treatment
CompanyDrug

Gilead’s Seladelpar Wins China Hainan Approval for PBC Treatment

Alphamab JSKN003 ADC FDA Breakthrough Therapy Targets Ovarian Cancer
CompanyDrug

Alphamab JSKN003 ADC FDA Breakthrough Therapy Targets Ovarian Cancer